December 19, 2019
Amneal Pharmaceuticals has issued a voluntary recall of Ranitidine tablets and Ranitidine syrup due to a possible presence of N-nitrosodimethylamine (NDMA) impurity.
Patients are asked to continue taking their medication and speak to their provider about alternate healthcare treatment options. Pharmacies will be asked to immediately stop dispensing Ranitidine.
Visit the FDA website for more information on the recalled products including product names, catalog numbers, lot numbers, and expiration dates.